# Nuuron

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nuuron

- Industry: Software
- Headquarters: Berlin, Germany
- Website: www.nuuron.com
- Total disclosed funding: $3.8M
- Latest round: Seed (Oct 21, 2024)
- Investors on record: 11

## About

Founded in 2023 and based in Berlin, Nuuron GmbH operates as a neuromodulation technology company. The company was founded by Fabian Queisner and Markus Müschenich. In October 2024, Nuuron GmbH raised EUR 3.5 million in seed funding led by High-Tech Gründerfonds, with participation from IBB Ventures, Caesar Ventures, and Business Angels Club Berlin-Brandenburg.

Nuuron develops Memory Pacemaker, which is a digital drug to treat Alzheimer's disease. The company’s therapy uses advanced VR and AR technologies to deliver ultra-high-frequency, digital-photonic stimuli to the brain through the retina. The digital drug activates the brain's memory system and improves memory formation and recall in Alzheimer's patients.

The company will use the funding to conduct clinical studies to develop its digital drug for treating Alzheimer's disease.

## Funding rounds

- Seed, Oct 21, 2024, $3.8M — IBB Ventures, High-Tech Gruenderfonds, BIF Partners, HBG Ventures GmbH, Rewari Investment GmbH, Caesar Ventures, FROG VISION GmbH, Mücke & Sturm Beteiligungsgesellschaft mbH, Thilo Veil Beteiligungs-GmbH, Cimexia GmbH, LK4Ventures GmbH

## Investors

- IBB Ventures (https://capitalatlas.ai/funds/ibb-ventures) — Seed
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- BIF Partners — Seed
- HBG Ventures GmbH — Seed
- Rewari Investment GmbH — Seed
- Caesar Ventures (https://capitalatlas.ai/funds/caesar-ventures) — Seed
- FROG VISION GmbH — Seed
- Mücke & Sturm Beteiligungsgesellschaft mbH — Seed
- Thilo Veil Beteiligungs-GmbH — Seed
- Cimexia GmbH — Seed
- LK4Ventures GmbH — Seed